GARDP Webinar: How can non-profit drug developers counter AMR?
Antibiotics underpin modern medicine and are critical for pandemic preparedness. The aim of the webinar is to highlight the value of the nonprofit R&D business model in tackling antimicrobial resistance (AMR). It will look at the importance of public-private partnerships, such as GARDP, in accelerating the development and access to new and improved treatments for drug-resistant infections. The webinar will feature experts who have been deeply involved in the non-profit public health sector and are committed to introducing new health treatments for priority public health needs.
We will be joined by:
Laura Piddock, Scientific Director, GARDP
Pietro Turilli, Senior Vice President, External Affairs, TB Alliance
Monique Wasunna, Director, DNDi Eastern Africa
Moderated by: Claire Doole
More information is available on our website: https://gardp.org/events/webinar-how-can-a-nonprofit-drug-development-model-counter-amr/
The registration link is available here: Register here
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!